On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.
Related Posts
Whether or not this summer’s Transformers: Rise of the Beasts…
A man in India recently had the misfortune of becoming…